Premium
O1‐04‐01: Results of the MIDAS trial: Effects of docosahexaenoic acid on physiological and safety parameters in age‐related cognitive decline
Author(s) -
YurkoMauro Karin,
McCarthy Deanna,
BaileyHall Eileen,
Nelson Edward B.,
Blackwell Andrew
Publication year - 2009
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2009.05.214
Subject(s) - docosahexaenoic acid , tolerability , episodic memory , medicine , placebo , cognitive decline , cognition , neuroprotection , adverse effect , polyunsaturated fatty acid , disease , dementia , fatty acid , psychiatry , biology , biochemistry , alternative medicine , pathology